Market Report

Apheresis Market by Procedure, Technology and Products to 2020

Press Release   •   Sep 07, 2015 11:41 BST

The global apheresis market is expected to reach USD 2.5 billion by 2020, growing at a CAGR of 11.2% during the forecast period (2015 to 2020). The market is mainly driven by the rising incidences of blood disorders and chronic diseases, increasing demand for source plasma from biopharmaceutical companies, and increasing demand for blood for transfusion in surgical procedures and accident & trauma cases. Apheresis is an essential tool in modern medical practices in the blood industry. It is a process in which the blood of a donor/patient is passed through a medical device, which separates one or more components of the blood and returns the remaining with or without extra corporeal treatment or replacement of separated components.

Browse 139 market data table & 45 figure spread through 195 page and in-depth TOC on "Apheresis Market" .

On the basis of applications, the apheresis market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, LDL apheresis, and others (photopheresis, lymphapheresis, and extracorporeal immunoadsorption). The plasmapheresis segment accounted for the largest share—46.5%—of the global apheresis market in 2014. The large share of plasmapheresis is attributed to the increasing demand of source plasma for transfusion from hospitals and for fractionation from biopharmaceutical companies. In this report, the apheresis market is segmented by procedure, product, technology, application, and region. The apheresis market, by procedure, is mainly segmented into apheresis/automated blood collection and therapeutic apheresis. In 2014, the automated blood collection segment accounted for the largest share of approximately 77.2% of the apheresis market, and is expected to grow at a CAGR of 10.7% during the forecast period. Growth in this segment is mainly attributed to the increasing severity of blood shortage and growing concern regarding blood safety, and increasing incidences of blood disorders and chronic diseases.

For more inquiry on this report at .

Major players in the apheresis market are Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Medica S.p.A. (Italy), Kaneka Corporation (Japan), Nikkiso Co., Ltd. (Japan) and Therakos, Inc. (U.S.).

Priced at $4650 for a single user PDF, a discount on “Apheresis Market by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis), Procedure (Therapeutic Apheresis, Donor Apheresis/Apheresis Blood Donation), Technology & by Product - Global Forecast to 2020research report can be requested at .

(Contact us @ + 1 888 391 5441)